Abstract:ABSTRACT The ability to adapt to a changing environment provides a selective advantage to microorganisms. In the case of many pathogens, a large change in their environment occurs when they move from a natural setting to a setting within a human host and then during the course of disease development to various locations within that host. Two clinical isolates of the human fungal pathogen Cryptococcus neoformans were identified from a collection of environmental and clinical strains that exhibited a mutator phenotype, which is a phenotype which provides the ability to change rapidly due to the accumulation of DNA mutations at high frequency. Whole-genome analysis of these strains revealed mutations in MSH2 of the mismatch repair pathway, and complementation confirmed that these mutations are responsible for the mutator phenotype. Comparison of mutation frequencies in deletion strains of eight mismatch repair pathway genes in C. neoformans showed that the loss of three of them, MSH2 , MLH1 , and PMS1 , results in an increase in mutation rates. Increased mutation rates enable rapid microevolution to occur in these strains, generating phenotypic variations in traits associated with the ability to grow in vivo , in addition to allowing rapid generation of resistance to antifungal agents. Mutation of PMS1 reduced virulence, whereas mutation of MSH2 or MLH1 had no effect on the level of virulence. These findings thus support the hypothesis that this pathogenic fungus can take advantage of a mutator phenotype in order to cause disease but that it can do so only in specific pathways that lead to a mutator trait without a significant tradeoff in fitness. IMPORTANCE Fungi account for a large number of infections that are extremely difficult to treat; superficial fungal infections affect approximately 1.7 billion (25%) of the general population worldwide, and systemic fungal diseases result in an unacceptably high mortality rate. How fungi adapt to their hosts is not fully understood. This research investigated the role of changes to DNA sequences in adaption to the host environment and the ability to cause disease in Cryptococcus neoformans , one of the world’s most common and most deadly fungal pathogens. The study results showed that microevolutionary rates are enhanced in either clinical isolates or in gene deletion strains with msh2 mutations. This gene has similar functions in regulating the rapid emergence of antifungal drug resistance in a distant fungal relative of C. neoformans , the pathogen Candida glabrata . Thus, microevolution resulting from enhanced mutation rates may be a common contributor to fungal pathogenesis.

A Rapidly Reversible Mutation Generates Subclonal Genetic Diversity and Unstable Drug Resistance

Rapidly reversible mutations generate subclonal genetic diversity and reversible drug resistance

Genome-wide Mapping of Spontaneous Genetic Alterations in Diploid Yeast Cells

Mutator-driven Continuous Genome Evolution of Saccharomyces Cerevisiae

Genome-Wide Mutation Avalanches Induced in Diploid Yeast Cells by a Base Analog or an APOBEC Deaminase

A transient burst of mutations occurs during the normal development of yeast colonies

Preferential Protection of Genetic Fidelity Within Open Chromatin by the Mismatch Repair Machinery

Mapping Chromosomal Instability Induced by Small-Molecular Therapeutics in a Yeast Model

Distinct evolutionary trajectories following loss of RNA interference in Cryptococcus neoformans

Mismatch Repair of DNA Replication Errors Contributes to Microevolution in the Pathogenic Fungus Cryptococcus neoformans

In Vivo Evolution of Drug-Resistant Mycobacterium Tuberculosis in Patients During Long-Term Treatment

Spontaneous single-nucleotide substitutions and microsatellite mutations have distinct distributions of fitness effects

Evolving a favorable distribution for mutation effects

Common regulatory mutation increases single-cell survival to antibiotic exposures in .

Loss of Heterozygosity by SCRaMbLEing

Bursts of Genomic Instability Potentiate Phenotypic and Genomic Diversification in Saccharomyces cerevisiae

Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance

Disruption of Transcriptional Coactivator Sub1 Leads to Genome-Wide Re-distribution of Clustered Mutations Induced by APOBEC in Active Yeast Genes

Highly recurrent multi-nucleotide mutations in SARS-CoV-2

Modulation of Base Specific Mutation and Recombination Rates Enables Functional Adaptation within the Context of the Genetic Code